HYALOVET

Country: New Zealand

Language: English

Source: Ministry for Primary Industries

Active ingredient:

sodium hyaluronate

Available from:

Virbac New Zealand Limited

INN (International Name):

sodium hyaluronate

Composition:

sodium hyaluronate 10 g/litre

Therapeutic area:

Anti-inflammatory

Authorization status:

ACVM Registered

Authorization date:

1984-12-21

Summary of Product characteristics

Hyalovet
Carton label text
May 2023
KEEP OUT OF REACH OF CHILDREN
FOR ANIMAL TREATMENT ONLY
HYALOVET

20
RESTRICTED VETERINARY MEDICINE
Sodium Hyaluronate Injection
Each 2 mL contains as active ingredient, 20 mg sodium hyaluronate
INDICATIONS:
For the treatment of joint disease in horses including:
Osteoarthritis with or without inflammatory signs; Acute or chronic
synovitis;
Degenerative processes in articular cartilage; Dry joint disease.
As an adjuvant used in the treatment of chip fractures or sesamoid
fractures.
ADMINISTRATION:
One syringe (2mL) intra-articularly per joint. More than one joint can
be treated at the same time.
Repeat if necessary after one or more weeks.
STORAGE:
Store at room temperature (below 25C). Do not freeze. Remaining
solution should be discarded.
Registered pursuant to the ACVM Act 1997, No A004922
See www.foodsafety.govt.nz for registration conditions
Registered to and distributed by:
VIRBAC NEW ZEALAND LTD
26 – 30 Maui Street, Pukete Park, Hamilton
Visit us at nz.virbac.com
Batch:
Expiry:
Hyalovet
Carton label text
May 2023
HYALOVET

20
ad us. vet.
RESTRICTED VETERINARY MEDICINE
Hyaluronic acid solution for horses:
Injectable solution for intra-articular administration
COMPOSITION:
Highly viscous aqueous solution of a defined molecular fraction of
purified hyaluronic acid.
One preloaded syringe or one vial contains:
Natrii Hyaluronas
20 mg
Excip.pro. ini
ad 2 mL
PROPERTIES / EFFECTS:
Hyaluronic acid is the prototype of a wide range of saccharide
biopolymers (glycosaminoglycans or mucopolysaccharides), important
components of all extracellular tissue structures including cartilage
and
synovial fluid. The active substance of HYALOVET

is a specific
hyaluronic acid fraction of defined molecular chain length (2500 –
3500
saccharide units) with a high degree of purity, which possesses
particular
biochemical, chemical-physical and pharmacological properties.
The intra-articular injection of this biological substance into the
diseased
horse joint results in improved joint